News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Vir Biotechnology rallied after a Phase-3 trial win, pushing market capitalization to about $2.34 billion.
  • Valuation appears tight versus near-term binary catalysts; cautious long recommended with limited position size and a hard stop.
  • Celestica trades near $223 after a steep fall from its 52-week peak while reporting $545 million in free cash flow.
  • Recommend a tactical 45-day short on Celestica driven by sagging AI revenue expectations.
  • Event-driven stock trades dominated the hour, with catalyst-driven biotech moves and targeted shorts in AI-supply names.

Latest Articles

Oman Proposes Regional, Fee-Based Mechanism for Management of Strait of Hormuz

Oman Proposes Regional, Fee-Based Mechanism for Management of Strait of Hormuz

Oman has offered Iran a regional framework to oversee the Strait of Hormuz that would use voluntary user fees and shared management rather than granting Tehran exclusive control. The plan, which reportedly has regional support and is modeled on the Strait of Malacca funding system, arrives as the United States temporarily halted a campaign of air s…

KIDZ AI Issues Shareholder Letter Addressing Disconnect Between Current Share Price and Fundamentals

KIDZ AI Issues Shareholder Letter Addressing Disconnect Between Current Share Price and Fundamentals

KIDZ AI Inc. disclosed a significant disconnect between its current low market valuation and its strong fundamentals, including a net cash position nearly three times its market cap and a $44.6 million contracted GPU compute services agreement. The company has initiated a share repurchase program, plans to increase it to $3 million, and expects to …

Tokyo shares retreat; Nikkei 225 posts 3.83% decline to one-month low

Tokyo shares retreat; Nikkei 225 posts 3.83% decline to one-month low

Japan's equity market closed sharply lower on Tuesday with the Nikkei 225 sliding 3.83% to a fresh one-month low. Losses were concentrated in the Paper & Pulp, Transport and Communication sectors, while market breadth showed more decliners than advancers. Volatility on Nikkei options eased and major commodity and currency markets posted declines.

Everplay Sticks to FY26 Targets as First-Half Trading Supports Outlook

Everplay Sticks to FY26 Targets as First-Half Trading Supports Outlook

Everplay said its first-half trading gives it confidence that it will meet market expectations for the full year, reiterating guidance for modest top-line and EBITDA growth in FY26. Revenue is expected to rise 6% to £175.3 million and EBITDA 5% to £50.7 million, with earnings skewed toward the second half as the bulk of major releases are scheduled…

Luceco Lifts FY27 and FY28 EBITA Guidance After Robust H1 2026 Performance

Luceco Lifts FY27 and FY28 EBITA Guidance After Robust H1 2026 Performance

Luceco reported a 13% year-over-year revenue increase in the first half of 2026, driven by accelerating sales in the second quarter and a surge in Energy Transition products. First-half EBITA rose 14% to about .8 million, while margins improved modestly. The group maintained its full-year 2026 EBITA target above 0 million and upgraded expectation…

Buy Genmab Ahead of H1: Darzalex Strength Could Trigger a Re-rate

Buy Genmab Ahead of H1: Darzalex Strength Could Trigger a Re-rate

Genmab looks positioned to beat H1 revenue expectations on Darzalex strength and recent approvals momentum. The shares trade at $28.80 with a $17.9B market cap, reasonable 21.6x PE and improving technicals. We recommend a mid-term long trade into H1 results with a $29.00 entry, $34.00 target and $26.50 stop—duration ~45 trading days.

Forterra H1 revenue slides 13.5% as demand softens across product lines

Forterra H1 revenue slides 13.5% as demand softens across product lines

Forterra, the UK building products manufacturer, reported a 13.5% fall in first-half revenue to £168.80 million and a 9.7% decline in adjusted EBITDA to £27 million. The company cited weaker demand across its product range, implemented modest price rises and surcharges, cut production and reorganised support functions to target annual savings of £2…

NWF Group posts modest revenue gains as divisions diverge in performance

NWF Group posts modest revenue gains as divisions diverge in performance

NWF Group recorded a 1.9% rise in revenue to £920.30 million for the fiscal year ended May 31, 2026. Headline operating profit increased by 3.1% to £16.80 million, while headline earnings per share fell 3.2% to £0.18. Pretax profit was reported at £12.5 million and net debt stood at £60.50 million. Management proposed a 3.6% dividend increase, exte…

Australian Shares Tick Higher, S&P/ASX 200 Reaches One-Month Peak

Australian Shares Tick Higher, S&P/ASX 200 Reaches One-Month Peak

The S&P/ASX 200 closed higher on Tuesday, gaining 0.60% to record a one-month high, led by advances in the Consumer Discretionary, Telecoms Services and Healthcare sectors. Wisetech Global, Guzman Y Gomez and Viva Energy were among the session's top performers, while DroneShield, Stanmore Coal and Megaport posted the steepest declines. Broader mark…

Unite Group H1 adjusted earnings slip as interest costs and disposals bite

Unite Group H1 adjusted earnings slip as interest costs and disposals bite

Unite Group reported a 2% year-on-year decline in adjusted net income for the first half of 2026 to £142 million, as rising interest expenses, disposals completed in 2025 and softer occupancy weighed on results. The group recorded an IFRS pretax loss of £417.10 million following a 6.4% reduction in property valuations, but reiterated full-year adju…

Storytel Lifts 2026 Adjusted EBITDA Target as Q2 Margins Improve

Storytel Lifts 2026 Adjusted EBITDA Target as Q2 Margins Improve

Swedish audiobook and publishing company Storytel reported a 12% rise in second-quarter net sales, margin expansion, and a higher full-year adjusted EBITDA target for 2026. Strong performance in the publishing segment, aided by the May closing of the Overamstel acquisition, contributed to top-line gains and improved gross margins.

Creo Medical Posts 45% H1 2026 Revenue Gain, Narrows Operating Loss

Creo Medical Posts 45% H1 2026 Revenue Gain, Narrows Operating Loss

Creo Medical reported H1 2026 revenue of £3.2 million, a 45% rise year-over-year, while trimming operating costs by 15% and cutting its operating loss by more than 25%. Growth was led by increased use of its Speedboat, SpydrBlade Flex and MicroBlate Fine products and expansion into new markets, notably Latin America. Management kept full-year reven…

Dotdigital posts modest growth as recurring revenue base strengthens

Dotdigital posts modest growth as recurring revenue base strengthens

Dotdigital reported £90.9 million in revenue for fiscal 2026, an 8% increase year-over-year. The company said the performance matched market expectations, with acquisitions and AI-enabled product expansion supporting recurring revenue growth and a shift toward higher-margin offerings. Management expects to meet market forecasts for fiscal 2027 desp…

Croda posts 4.6% organic sales rise in H1 2026 as Consumer Care drives growth

Croda posts 4.6% organic sales rise in H1 2026 as Consumer Care drives growth

Croda reported 4.6% organic sales growth for the first half of 2026, led by strength in its Consumer Care division. Group sales reached £880.50 million, marginally ahead of the £879.42 million consensus from two analysts. Adjusted operating profit rose 6.7% organically to £155.80 million, lifting the adjusted operating margin to 17.7%, though preta…

Taiwan share index edges down as select sectors weigh on market

Taiwan share index edges down as select sectors weigh on market

Taiwan equities closed lower on Tuesday, with the Taiwan Weighted index down 0.05%. Gains in a handful of mid-cap names were offset by double-digit declines in several stocks, while commodity and currency moves showed modest shifts during the session. Market breadth data reported an atypical 0 to 0 figure for advancing versus declining issues on th…